WEBINAR: Genetic Susceptibility, Exposure Markers, and the Talc Experience

Posted by David Schwartz on Posted on

Innovative Science Solutions will be speaking at the upcoming Toxic Torts and Product Liability Webinar to be hosted by Mayer Brown on Thursday, January 19, 2017 (1:00 p.m. – 2:30 p.m. EST). Emerging Science and Toxic Tort Litigation: Genetic Susceptibility, Exposure Markers, and the Talc Experience The webinar features a presentation by Dr. Suresh Moolgavkar
Read More

Does Carcinogenicity Classification Make Any Sense?

Posted by David Schwartz on Posted on

In a recent trial involving allegations that asbestos-contaminated talc caused the plaintiff’s mesothelioma (the Lamonica case), plaintiff counsel (Scott Frost) was having a difficult time impeaching the opinions of the defense pathologist (Dr. Mossman). After spending some time trying to impeach her opinions based on her financial payments, Frost turned to another tried and true
Read More

Jurors in Toxic Tort Litigation Take Genetic Issues Seriously

Posted by David Schwartz on Posted on

This article was authored by David Schwartz, PhD and Kirk Hartley, Esq.  This post previously appeared on The Goldberg Segalla Asbestos Case Tracker.
Read More

The Increasing Relevance of Social Media to Adverse Drug Reaction Reporting

Posted by David Schwartz on Posted on

Adverse event data from protocol-driven, controlled clinical trials forms the backbone of any rigorous safety assessment on a new drug product. Nevertheless, lawyers defending pharmaceutical agents in product liability litigation must maintain a detailed awareness of spontaneously reported adverse events associated with drug exposures. As part of this effort, a good litigator must develop an
Read More

Big Data and New Technology – ISS Presenting at The 10th Annual Gibbons E-Discovery Conference

Posted by David Schwartz on Posted on

Dr. David Schwartz of Innovative Science Solutions will be presenting at the upcoming 10th Annual Gibbons E-Discovery Conference being held in West Orange (New Jersey) on November 18, 2016. 
Read More

Follow the Science Not the Money

Posted by David Schwartz on Posted on

This post was authored by Joseph Huggard, the General Manager of The Huggard Consulting Group who has spent more than 20 years working on a broad range of high profile issues with a particular emphasis on the use and communication of robust science, better regulation and regulatory impact assessment. Joe is highly regarded for his
Read More

The Future of Asbestos Litigation – Linking Genomic Science with Rigorous Exposure Assessment

Posted by David Schwartz on Posted on

The vast majority of malignant mesothelioma (MM) cases are asbestos related, yet the majority of individuals exposed to asbestos (even relatively high doses of amphibole asbestos fibers) do not develop MM. Many have concluded from this observation that there may be some genetic factor or factors that make some individuals more prone to mesothelioma than
Read More

new report:  asbestos science for toxic tort lawyers (2nd Edition released)

Posted by David Schwartz on Posted on

As we have highlighted in our blog over the past couple of years, there is a revolution underway in toxic tort litigation. This revolution involves the use of genomic data to define tumor types, to establish causation, and to establish alternate cause arguments. Genomic and other molecular science findings and legal issues continue to take on additional
Read More

5 Ways to apply Genomic Science to your asbestos cases

Posted by David Schwartz on Posted on

Many lawyers involved with asbestos litigation recognize the importance of maintaining an awareness of the scientific literature related to genomics in the context of malignant mesothelioma (MM) and lung cancer (LC).
Read More

3 Use Cases that Highlight the Need For Scientific Publication Monitoring

Posted by David Schwartz on Posted on

In a previous post, we outlined the positive impact of comprehensive science monitoring Science in The Courtroom: How to best prepare for a Science-Based Controversy. In this post, we develop that theme and cover some remarkable use cases demonstrating how critical it is to maintain a robust mechanism to protect organizations from the ever-present threat
Read More